Summary The mutagenic and cytotoxic activity of two newly synthesized doxorubicin derivatives and of one daunorubicin derivative were studied in V79 Chinese hamster cells and bacteria (Salmonella typhimurium and Escherichia coli). The results showed that all the compounds tested were cytotoxic and mutagenic for both prokaryotic and eukaryotic cells. However, in both systems, the two 4-desmethoxy-and the 4'-desoxyderivatives were more active than the parent compounds, indicating that modifications in the aglycone or in the sugar moiety can produce appreciable changes in the biological properties of the anthracycline antibiotics. The in vitro activities observed in this study correlated with the in vivo antitumour potency.
Doxorubicin and daunorubicin are effective agents for the treatment of human malignant diseases (Arcamone et al., 1969; Blum & Carter, 1974; Di Marco et al., 1963) . The mechanism of action of these agents is generally considered to involve the insertion of the planar ring system into DNA and the consequent inhibition of the DNA replication and transcription processes (Zunino et al., 1972; Meriwether & Bachur, 1972; Theologides et al., 1968) . However, it has been shown (Sinha, 1980; Konopa, 1983 ) that these agents may be activated to reactive intermediates that can covalently react with DNA. Moreover, several authors have proposed other cellular sites as targets for the biological action of anthracycline antibiotics (Tritton & Yee, 1982; Duarte-Karim et al., 1976; Scheulen et al., 1982) . In any event, when searching for more effective and/or less toxic anticancer agents of this class, it should be kept in mind that their interaction with DNA may result in a genotoxic effect and eventually in carcinogenesis. Studies on the structure-activity relationships have indicated that some structural features of these antitumour antibiotics are important determinants for their binding to DNA. It has been shown (Arcamone et al., 1975; Zunino et al., 1972) that modifications in the amino sugar moiety, as well as in the aglycone moiety can change the ability of these molecules to bind to DNA and eventually their biological properties.
With the aim of elucidating the relationships between the molecular structure and biological properties of the anthracycline antibiotics, doxorubicin, daunorubicin and their derivatives 4-desmethoxydoxorubicin, 4-desmethoxydaunorubicin and 4'-desoxydoxorubicin were compared for their cytotoxic and mutagenic activity in two in vitro biological systems, i.e., the bacterial systems employing Escherichia coli K12 and Salmonella, typhimurium Ames strains, and the mammalian cell system V79/HGPRT.
Materials and methods

Chemicals
Doxorubicin, daunorubicin and the new derivatives 4-desmethoxydoxorubicin, 4'-desoxydoxorubicin and 4-desmethoxydaunorubicin were kindly provided by Farmitalia-Carlo Erba. Their chemical structures are shown in Figure 1 .
Bacterial strains
The bacterial strains used were the following (Bachmann, 1972; Ames et al., 1975) At the end of both acute and prolonged treatment, all the cultures were washed x4 with medium without FCS.
Assay of the mutagenic and cytotoxic activity of the drugs Cells were plated 200 per 50mm dish (4 replicates) for the determination of the induced toxicity (surviving fraction) and 2 x 105 cells per 100 mm dish (5 replicates) for the selection of mutants according to the previously described technique (Abbondandolo et al., 1976) . One plate containing 7.5 x 105 cells was also made to propagate the culture for the selection at the appropriate expression time. We found that the optimum expression time was 7 days after treatment. Mutants defective in the hypoxanthine-guanine phosphorybosyl-transferase were selected by adding 6-thioguanine 1 h after plating, at the final concentration of 4 ,ug ml -. Both survival and mutation plates were stained with 1% methylene blue 7 days after plating and colonies were scored macroscopically.
Results
The mutagenic activity of doxorubicin, daunorubicin and their derivatives 4'-desoxydoxorubicin, 4-desmethoxydoxorubicin and 4-desmethoxydauno- rubicin was assayed on TA1535, TA1538 and their derivatives TA100 and TA98 Salmonella typhimurium strains. None of the compounds tested induced any revertant on the TA1535 strain, whereas they induced a significant number of revertants on TA1538. The mutagenic response was enhanced in the strains with the pKM101 plasmid, where all the compounds were mutagenic; TA98 showed a higher sensitivity than TA100 (Figure 2 ). The addition of S-9 mix for metabolic activation did not modify the mutagenic response of either of these strains (data not shown). The derivatives of doxorubicin and daunorubicin were more active than their respective parent compounds, except for TA98, where 4-desmethoxydaunorubicin is as mutagenic as daunorubicin. The test of selective toxicity for DNA repairdeficient E. coli K12 strains showed that none of the anthracycline antibiotics has antibacterial activity on the wild-type strain AB1 157, whereas an appreciable antibacterial activity was found on AB2463 (recA) and on AB2480 (recAuvrA) strains (data not shown).
On V79 Chinese hamster cells, doxorubicin and daunorubicin were found to be weakly mutagenic, whereas their derivatives showed a more marked activity, although at doses that sharply reduced the survival of the cells (Figure 3, lower part) . However, when the mutagenic activity of the drugs is compared at equitoxic doses (e.g. 10% survival), only the 4'desoxydoxorubicin induced a number of mutants significantly higher than the other compounds (Figure 4) . Surviving fraction (log) Figure 4 The mutagenic activity (expressed as number of 6-thioguanine-resistant clones 10-6 colony forming cells) of doxorubicin, daunorubicin and their derivatives, plotted against the surviving fraction. The regression curves are shown, and vertical bars represent the s.e. of the curves.
All the compounds were highly cytotoxic at doses varying from 0.05-0.5pgml-'. 4-desmethoxydaunorubicin and 4-desmethoxydoxorubicin were the most active, since they reduced the surviving fraction by >90% at 0.25 gml-' (Figure 3 , upper part). These results were obtained when the V79 cells were treated with the drugs for 1 h at 37'C; when the treatment was prolonged for 24 h, the mutagenic effect did not increase, whereas the cytotoxicity did dramatically. In fact, at doses from 0.001-0.005pgml-1, no mutagenic effect could be found, and only at 0.005 pg ml -I was a slight increase in the number of 6-thioguanine-resistant clones observed. In contrast, doses higher than O.Olgml-1 for 24h resulted in death of all the cells (data not shown).
Another interesting finding is that in the presence of S-9 mix, both the mutagenic and cytotoxic effects were suppressed (Table I) . Although the production of inactive metabolites is consistent with this finding, the observation that the anthracycline antibiotics, after metabolic activation, bind to microsomal proteins is relevant to this point (Scheulen et al., 1982) .
Discussion
As already reported for doxorubicin and daunorubicin (Seino et al., 1978; Au et al., 1981; Umezawa et al., 1978; Benedict et al., 1977) , all 5 compounds were highly mutagenic in the Ames test even without S-9 mix. In contrast, on V79 Chinese hamster cells the mutagenicity: cytotoxicity ratio was low. It is therefore possible that the induced toxicity on V79 cells results at least in part from damage to cellular targets other than DNA.
Several mechanisms have been proposed to explain the biological effects of the anthracycline antibiotics. Intercalation into double helical DNA and subsequent inhibition of DNA and/or RNA synthesis have been thought to be the main molecular effect of these compounds (Zunino et al., 1972; Meriwether & Bachur, 1972; Theologides et al., 1968) . Additional interactions with other aDimethyl-nitrosamine 5 mM was used as positive control for the metabolic activation.
bMutation frequency = 6-thioguanine-resistant clones 10 6 colony forming cells.
cCells were treated with the drug at 0.25 pg ml-for 1 h. cellular components have been observed, in particular with the cell surface (Tritton & Yee, 1982; Duarte et al., 1976; Scheulen, 1982) . In addition, the anthracycline antibiotics can be metabolized in living cells to chemical products able to react with cellular macromolecules and can participate in oxidation-reduction reactions (Arcamone et al., 1969); Sihna (1980) has shown that enzymatically activated doxorubicin and daunorubicin alkylate DNA probably via the formation of a quinone methide intermediate. Moreover, Scheulen et al. (1982) have proposed that the enzymatic activation of these substances can lead to the formation of reactive intermediates that covalently bind to cellular proteins.
In contrast, the mutagenic activity of these substances in eukaryotic cells shown in this and other studies (Suter et al., 1980; Marquardt et al., 1976) indicates that anthracycline antibiotics introduce lesions in DNA that lead to errors during replication and/or repair. The nature of the damage and the way in which the cells deal with it can be inferred from data obtained in S. typhimurium with and without pKM101 plasmid and on E. coli K12 strains with different repair capabilities. The different responses of TA1535 and TA1538 to the five compounds suggest that the intercalation of the molecule into DNA is probably involved in the mutagenicity of anthracycline antibiotics. This does not exclude the possibility that other metabolic products formed inside the cells may interact with DNA, but only indicates that these compounds are frameshift mutagens.
The data obtained on E. coli K12 derivatives with different repair capabilities clearly show that the compounds interact with bacterial DNA. The higher toxicity exerted on the recA strain AB2463 suggests that a recA-dependent pathway is required for repair of the lesion.
These observations also apply to the doxorubicin and daunorubicin derivatives. However, it is evident from the present data that the derivatives are more cytotoxic and more mutagenic than the parent compounds, both in prokaryotic and in eukaryotic systems. These differences may be due to the differences in the physicochemical properties as a consequence of the modifications introduced in the anthracycline aglycone or in the amino sugar moiety (Di Marco et al., 1978a, b) . These results are in agreement with observations that the removal of the methoxyl group at position 4 of the aglycone causes a marked increase in cytotoxicity against HeLa cells in vitro (Supino et al., 1977) and also an increase in antitumour potency , 1978b .
A slightly increased effectiveness has also been reported with the 4'desoxy-derivative (Di Marco et al., 1978a) . These modifications may alter the potency of the antracycline antibiotics in several ways; in particular, the increased intracellular accumulation may play a relevant role (Di Marco et al., 1978a, b) .
